Mechanism of hormone action
Mechanism of hormone action: receptors, second messengers and receptor disorders
How hormones act, for FCPS Part 1: surface receptors using cAMP, IP3 and DAG, cGMP, tyrosine kinase and JAK–STAT, and intracellular steroid receptors. Links each messenger to obstetric drugs, ovulation induction, antenatal steroids and receptor diseases.
Two families of hormone
| Feature | Peptides, glycoproteins, catecholamines | Steroids, thyroid hormone, vitamin D |
|---|---|---|
| Storage | Secretory granules; released by exocytosis | Not stored: made on demand and diffuse out as made |
| Transport | Mostly unbound in plasma; short half-life | On binding proteins (SHBG, CBG, TBG); longer half-life |
| Receptor | Cell surface | Intracellular (cytoplasm or nucleus) |
| Speed | Seconds to minutes | Hours (transcription and protein synthesis) |
- Steroid-making cells such as the corpus luteum take most of their cholesterol from plasma LDL by receptor-mediated endocytosis through the LDL receptor.
- hCG lasts much longer than LH, though both bind the same LH/hCG receptor, because its beta subunit carries a carboxy-terminal extension rich in sialic acid; sialylated sugars delay hepatic clearance. One injection acts for days (the IVF trigger), which also raises the risk of ovarian hyperstimulation.
G protein-coupled receptors (seven transmembrane)
- The receptor makes the alpha subunit swap GDP for GTP; the active alpha subunit acts on its enzyme until its own GTPase hydrolyses GTP back to GDP, which switches it off.
| G protein | Enzyme and messenger | Examples |
|---|---|---|
| Gs | Activates adenylate cyclase, raises cAMP | FSH, LH, hCG, TSH, ACTH, PTH, glucagon, ADH (V2), beta-adrenergic, calcitonin, H2 |
| Gi | Inhibits adenylate cyclase, lowers cAMP | D2 (dopamine on lactotrophs), alpha-2, M2, opioid, somatostatin |
| Gq | Activates phospholipase C: PIP2 splits into IP3 and DAG | GnRH, TRH, oxytocin, ADH (V1), alpha-1, angiotensin II, PGF2-alpha, M1 and M3 |
- cAMP acts through protein kinase A. cAMP binds the regulatory subunits of PKA (two regulatory, two catalytic), freeing the catalytic subunits to phosphorylate enzymes within minutes.
- cAMP also acts slowly on genes: PKA phosphorylates CREB (cAMP response element-binding protein), which switches on genes such as aromatase in granulosa cells within hours of FSH. Phosphodiesterase degrades cAMP and ends the signal.
- Each step activates many molecules, so tiny hormone concentrations give large responses (amplification).
- Gq pathway: IP3 opens the IP3 receptor calcium channel on the endoplasmic (sarcoplasmic) reticulum; DAG with calcium activates protein kinase C.
- ADH: V2 receptors (Gs, cAMP) in the collecting duct cause PKA to insert aquaporin-2 channels into the luminal membrane; V1 receptors (Gq) on vessels cause vasoconstriction.
Myometrium as a worked example
| Agent | Receptor and messenger | Uterine effect |
|---|---|---|
| Oxytocin, PGF2-alpha | Gq, IP3 raises calcium | Contraction |
| Phenylephrine and other alpha-1 agonists | Alpha-1, Gq | Contraction |
| Beta-2 agonists (salbutamol, terbutaline) | Gs, cAMP; PKA inhibits myosin light-chain kinase | Relaxation |
| Glyceryl trinitrate | NO, cGMP | Brief relaxation |
| Nifedipine | L-type calcium channel block (no receptor) | Relaxation |
- Calcium binds calmodulin, which activates myosin light-chain kinase: contraction. Adrenaline acts on both alpha-1 and beta-2, so its effect depends on dose.
Errors in G protein signalling
| Condition | Defect |
|---|---|
| Cholera toxin | ADP-ribosylates Gs-alpha, keeping it on |
| Pertussis toxin | ADP-ribosylates Gi, preventing its activation |
| McCune–Albright syndrome | Activating Gs-alpha mutation that abolishes GTP hydrolysis: ovaries secrete oestrogen without FSH or LH (peripheral precocious puberty), café-au-lait spots, fibrous dysplasia |
| Pseudohypoparathyroidism | Inactivating Gs-alpha mutation: no cAMP rise to PTH |
- Desensitisation: prolonged agonist exposure uncouples and internalises receptors. After many hours of oxytocin augmentation the uterus responds poorly, risking atonic PPH.
- GnRH must be pulsatile (every 60–90 minutes) to keep pituitary receptors responsive. A pump giving pulses induces ovulation in hypothalamic amenorrhoea; it cannot work if the pituitary is destroyed (Sheehan syndrome). Continuous agonist first causes a flare, then down-regulation. GnRH antagonists block without a flare.
Cyclic GMP
- Membrane guanylyl cyclase: ANP and BNP.
- Soluble guanylyl cyclase: nitric oxide. cGMP activates protein kinase G, which relaxes smooth muscle. Penile and clitoral erection uses parasympathetic NO and cGMP; PDE5 inhibitors prolong it.
Enzyme-linked receptors
- Receptor tyrosine kinase: insulin, IGF-1, growth factors. Autophosphorylation then IRS, PI3K and Akt, moving GLUT4 to the membrane. In gestational diabetes placental hormones blunt post-receptor steps; chronic hyperinsulinaemia down-regulates receptors.
- Cytokine receptors with JAK–STAT: GH, prolactin, erythropoietin, leptin (low leptin in very lean athletes suppresses GnRH).
Intracellular receptors
- Structure: ligand-binding domain, DNA-binding domain (zinc fingers), transactivation domain. Cortisol is the classic hormone whose receptor binds DNA directly at hormone response elements. Thyroid hormone is an amine but behaves like a steroid.
- Glucocorticoid receptor waits in the cytoplasm bound to heat shock protein 90; hormone releases it and the complex enters the nucleus. Oestrogen receptor is mainly nuclear.
- Thyroid hormone and vitamin D receptors sit on DNA as heterodimers with the retinoid X receptor. Calcitriol raises duodenal calcium absorption by inducing calbindin, so the effect takes days.
- Antenatal betamethasone works best after about 24 hours because new transcription is needed: alveolar type II pneumocytes increase surfactant.
- Tissue-selective modulators: the same receptor recruits different co-activators and co-repressors in each tissue. Tamoxifen is an antagonist in breast but an agonist in endometrium; raloxifene does not stimulate the endometrium; fulvestrant causes receptor degradation.
Receptor disorders
| Disorder | Receptor problem |
|---|---|
| Complete androgen insensitivity | Androgen receptor mutation; gene on the X chromosome, so X-linked, passed through carrier mothers; testosterone normal or high |
| Familial hypercholesterolaemia | LDL receptor deficiency: very high LDL, tendon xanthomas, early MI |
| Nephrogenic diabetes insipidus | V2 receptor or aquaporin-2 defect |
| Myasthenia gravis | Antibodies block and destroy postsynaptic nicotinic ACh receptors: fatigable ptosis and diplopia |
| Graves disease | Antibodies stimulate the TSH receptor |
| Type 2 diabetes, PCOS | Post-receptor insulin resistance and receptor down-regulation |
Obstetric drugs and their receptors
| Drug | Receptor and effect |
|---|---|
| Oxytocin | Oxytocin receptor (Gq); at high doses acts on V2: water retention, hyponatraemia |
| Atosiban | Blocks oxytocin and vasopressin V1a receptors |
| Ergometrine | Alpha-adrenergic and 5-HT2: uterine contraction and hypertension |
| Carboprost | FP receptor on uterus and bronchi: bronchospasm in asthma |
| Dicyclomine, oxybutynin | Block muscarinic M3: relax gut and bladder smooth muscle |
- Some drugs act without any receptor: antacids, osmotic diuretics (mannitol), chelating agents and bulk laxatives work by chemical or physical properties.
Remember Peptides are stored and act at the surface; steroids are made on demand and act in the nucleus.
Exam trap FSH and LH use cAMP; GnRH and oxytocin use IP3 and DAG. Do not mix the two levels of the axis.
Exam trap Insulin, GH and prolactin do not use cAMP: insulin uses a tyrosine kinase, GH and prolactin use JAK–STAT.
How FCPS asks about this
- cAMP acts through: protein kinase A; on genes via phosphorylated CREB.
- Phospholipase C is the messenger route of: GnRH, oxytocin, TRH, alpha-1 and V1 receptors.
- cGMP is the second messenger of: nitric oxide and ANP.
- Hormone acting through an intracellular receptor that binds DNA: cortisol (also other steroids, thyroid hormone, vitamin D).
- Why GnRH is given in pulses: pulses keep pituitary GnRH receptors responsive; continuous exposure down-regulates them.
- Why hCG lasts longer than LH: high sialic acid content of its beta-subunit tail.
- McCune–Albright defect: Gs-alpha that cannot hydrolyse GTP.
Test yourself on this topic
5 of the 94 questions in our bank on this topic. Choose an answer to see why every option is right or wrong.
Antenatal betamethasone reduces respiratory distress in preterm babies. Through glucocorticoid receptor–driven gene transcription, which fetal lung cells increase surfactant production?
Answer: Alveolar type II cells
Type II pneumocytes are cuboidal cells that make, store in lamellar bodies, and secrete surfactant. Glucocorticoids bind their intracellular receptors and increase transcription of surfactant proteins and enzymes of phospholipid synthesis, such as those making dipalmitoylphosphatidylcholine. They also speed structural maturation of the lung. Type I pneumocytes are thin cells for gas exchange and do not secrete surfactant.
Steroids and surfactant
- Target: type II pneumocytes
- Glucocorticoid receptor in nucleus
- More surfactant proteins and DPPC
- Stored in lamellar bodies
Remember Steroids switch on type II cells.
Exam trap Type II pneumocytes also act as stem cells for type I cells.
Why the other options are wrong
- Alveolar type I cells Thin gas-exchange cells; no surfactant.
- Alveolar macrophages Clear debris and surfactant; do not make it.
- Bronchiolar club cells Make some secretory proteins in bronchioles, not alveolar surfactant.
- Ciliated bronchial cells Clear mucus; no surfactant.
A woman with bipolar disorder planning pregnancy asks how lithium works. One proposed mechanism is that it damps signalling through Gq-coupled receptors by limiting recycling of PIP2. Which enzyme does lithium inhibit?
Answer: Inositol monophosphatase
After phospholipase C splits PIP2, IP3 is dephosphorylated in steps back to free inositol, which is reused to rebuild PIP2. Lithium inhibits inositol monophosphatase and related phosphatases, so inositol is depleted in overactive neurons and Gq-coupled signalling is reduced (the inositol depletion hypothesis). Lithium also inhibits glycogen synthase kinase-3. Its renal effects come from interference with V2-receptor cAMP signalling.
Lithium and IP3 recycling
- PIP2 to IP3 + DAG
- IP3 recycled to inositol
- Lithium blocks inositol monophosphatase
- Less PIP2: damped Gq signalling
Remember Lithium starves the inositol cycle.
Exam trap Lithium is linked to Ebstein anomaly if taken in the first trimester.
Why the other options are wrong
- Phospholipase C beta Lithium does not block PLC.
- Protein kinase C Not the classic lithium target.
- Adenylate cyclase Lithium reduces ADH-stimulated cAMP in the kidney, but this is not the inositol step.
- cAMP phosphodiesterase Not inhibited by lithium.
LH acting on theca cells raises cAMP, which activates protein kinase A. How does cAMP activate this enzyme?
Answer: Frees its catalytic subunits
Inactive protein kinase A is a tetramer of two regulatory and two catalytic subunits. Four cAMP molecules bind the regulatory subunits, which change shape and release the catalytic subunits. The free catalytic subunits phosphorylate serine and threonine residues on target proteins, including steroidogenic enzymes and the transcription factor CREB. When cAMP falls, the subunits reassociate.
PKA
- Tetramer: 2 regulatory + 2 catalytic
- cAMP binds regulatory subunits
- Catalytic subunits released
- Phosphorylate serine/threonine
Remember cAMP sets PKA's catalytic subunits free.
Exam trap PKA is a serine/threonine kinase, not a tyrosine kinase.
Why the other options are wrong
- Phosphorylates the catalytic subunit Not the activation mechanism.
- Opens a channel in the kinase PKA is not a channel.
- Moves it to the nucleus first Nuclear movement follows activation.
- Cleaves an inhibitory peptide No proteolysis is involved.
A woman in preterm labour is given a β2-agonist infusion, and her contractions weaken. The drug raises cAMP in myometrial cells. Which action of protein kinase A then relaxes the muscle?
Answer: Phosphorylates and inhibits MLCK
β2-receptors couple to Gs, raising cAMP and activating protein kinase A. PKA phosphorylates myosin light-chain kinase, reducing its affinity for calcium–calmodulin, so myosin is less phosphorylated and cross-bridge cycling falls. PKA also lowers intracellular calcium by promoting its uptake and extrusion. The net result is smooth muscle relaxation, as in bronchi.
β2 relaxation of smooth muscle
- β2: Gs, cAMP
- PKA activated
- PKA inhibits MLCK
- Less calcium, relaxation
Remember cAMP relaxes smooth muscle by disabling MLCK.
Exam trap β2-agonist tocolytics cause tachycardia, hyperglycaemia and hypokalaemia.
Why the other options are wrong
- Opens L-type calcium channels Would increase calcium and contraction.
- Activates phospholipase C Gq pathway; promotes contraction.
- Releases calcium from the SR Would promote contraction.
- Inhibits myosin phosphatase Would increase contraction.
A woman with hypothyroidism has raised prolactin because hypothalamic releasing hormone excess stimulates lactotrophs. Which of the following hormones acts mainly through a Gq-coupled receptor and IP3?
Answer: TRH
Thyrotrophin-releasing hormone binds a Gq-coupled receptor on thyrotrophs and lactotrophs, activating phospholipase C, IP3 and DAG. The rise in calcium triggers release of TSH and prolactin, which explains hyperprolactinaemia in primary hypothyroidism. TSH, FSH, LH and hCG are glycoprotein hormones whose receptors couple mainly to Gs and raise cAMP. GnRH, oxytocin and vasopressin at V1 receptors also use Gq.
Gq vs Gs hormones
- Gq: TRH, GnRH, oxytocin
- Gq: V1, α1
- Gs: TSH, FSH, LH, hCG
- Gs: V2, β, PTH
Remember Releasing hormones mostly use Gq; glycoproteins use Gs.
Exam trap CRH and GHRH are exceptions among releasing hormones: they use Gs.
Why the other options are wrong
- TSH Gs and cAMP.
- FSH Gs and cAMP.
- hCG Gs and cAMP.
- LH Gs and cAMP.
Where this sits in the CPSP syllabus
- Obstetrics & Gynaecology, Paper 2: Endocrinology, Mechanism of hormone action; receptors and second messengers
Read next
Drug dose pages
Doses, cautions and practical tips for drugs in this chapter.